Overlap between frontotemporal dementia and alzheimer's disease: Cerebrospinal fluid pattern and neuroimaging study

Journal of Alzheimer's Disease

Volumn 36, Issue 1, 2013, Pages 49-55

  Padovani, Alessandro ^a   Premi, Enrico ^a   Pilotto, Andrea ^a   Gazzina, Stefano ^a   Cosseddu, Maura ^a   Archetti, Silvana ^b   Cancelli, Vanessa ^a   Paghera, Barbara ^a   Borroni, Barbara ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Department of Paediatrics   (Italy)

Author keywords

Alzheimer's disease; amyloid ; cerebrospinal fluid; frontotemporal dementia; SPECT; tau

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR CHANGE; BRAIN PERFUSION; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL DEMENTIA; GAMMA CAMERA; GENOTYPE; HUMAN; MALE; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; ONSET AGE; PARIETAL LOBE; PRECUNEUS; PRIMARY PROGRESSIVE APHASIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEMANTIC DEMENTIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE;

EID: 84878868725     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-121969     Document Type: Article

References (42)

1. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998) Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 51, 1546-1554.
2. Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG (2005) The evolution and pathology of frontotemporal dementia. Brain 128, 1996-2005.
3. Seelaar H, Rohrer JD, Pijnenburg YA, Fox NC, van Swieten JC (2011) Clinical, genetic and pathological heterogeneity of frontotemporal dementia: A review. J Neurol Neurosurg Psychiatry 82, 476-486.
4. Whitwell JL, Dickson DW, Murray ME, Weigand SD, Tosakulwong N, Senjem ML, Knopman DS, Boeve BF, Parisi JE, Petersen RC, Jack CR Jr., Josephs KA (2012) Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: A case-control study. Lancet Neurol 11, 868-877.
5. Borroni B, Alberici A, Grassi M, Turla M, Zanetti O, Bianchetti A, Dalla VG, Rozzini R, Gilberti N, Bellelli G, Padovani A (2010) Is frontotemporal lobar degeneration a rare disorder? Evidence from a preliminary study in Brescia county, Italy. J Alzheimers Dis 19, 111-116.
6. Bernardi L, Frangipane F, Smirne N, Colao R, Puccio G, Curcio SA, Mirabelli M, Maletta R, Anfossi M, Gallo M, Geracitano S, Conidi ME, Di LR, Clodomiro A, Cupidi C, Marzano S, Comito F, Valenti V, Zirilli MA, Ghani M, Xi Z, Sato C, Moreno D, Borelli A, Leone RA, St George-Hyslop P, Rogaeva E, Bruni AC (2012) Epidemiology and genetics of frontotemporal dementia: A door-to-door survey in Southern Italy. Neurobiol Aging 33, 2948.e1-2948.e10.
7. Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EG, Onyike CU, Hillis AE, Josephs KA, Boeve BF, Kertesz A, Seeley WW, Rankin KP, Johnson JK, Gorno-Tempini ML, Rosen H, Prioleau-Latham CE, Lee A, Kipps CM, Lillo P, Piguet O, Rohrer JD, Rossor MN, Warren JD, Fox NC, Galasko D, Salmon DP, Black SE, Mesulam M,Weintraub S, Dickerson BC, Diehl-Schmid J, Pasquier F, Deramecourt V, Lebert F, PijnenburgY, Chow TW, Manes F, Grafman J, Cappa SF, Freedman M, Grossman M, Miller BL (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134, 2456-2477.
8. Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Ogar JM, Rohrer JD, Black S, Boeve BF, Manes F, Dronkers NF, Vandenberghe R, Rascovsky K, Patterson K, Miller BL, Knopman DS, Hodges JR, Mesulam MM, Grossman M (2011) Classification of primary progressive aphasia and its variants. Neurology 76, 1006-1014.
9. Anchisi D, Borroni B, Franceschi M, Kerrouche N, Kalbe E, Beuthien-Beumann B, Cappa S, Lenz O, Ludecke S, Marcone A, Mielke R, Ortelli P, Padovani A, Pelati O, Pupi A, Scarpini E, Weisenbach S, Herholz K, Salmon E, Holthoff V, Sorbi S, Fazio F, Perani D (2005) Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch Neurol 62, 1728-1733.
10. Borroni B, Anchisi D, Paghera B, Vicini B, Kerrouche N, Garibotto V, Terzi A, Vignolo LA, Di LM, Giubbini R, Padovani A, Perani D (2006) Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD. Neurobiol Aging 27, 24-31.
11. Alladi S, Xuereb J, Bak T, Nestor P, Knibb J, Patterson K, Hodges JR (2007) Focal cortical presentations of Alzheimer's disease. Brain 130, 2636-2645.
12. Woodward M, Jacova C, Black SE, Kertesz A, Mackenzie IR, Feldman H (2010) Differentiating the frontal variant of Alzheimer's disease. Int J Geriatr Psychiatry 25, 732-738.
13. Koedam EL, Van der Flier WM, Barkhof F, Koene T, Scheltens P, Pijnenburg YA (2010) Clinical characteristics of patients with frontotemporal dementia with and without lobar atrophy on MRI. Alzheimer Dis Assoc Disord 24, 242-247.
14. Graham A, Davies R, Xuereb J, Halliday G, Kril J, Creasey H, Graham K, Hodges J (2005) Pathologically proven frontotemporal dementia presenting with severe amnesia. Brain 128, 597-605.
15. Caine D, Patterson K, Hodges JR, Heard R, Halliday G(2001) Severe anterograde amnesia with extensive hippocampal degeneration in a case of rapidly progressive frontotemporal dementia. Neurocase 7, 57-64.
16. Hodges JR,Davies RR, Xuereb JH, CaseyB, Broe M, Bak TH, Kril JJ, Halliday GM(2004) Clinicopathological correlates in frontotemporal dementia. Ann Neurol 56, 399-406.
17. Baborie A, Griffiths TD, Jaros E, Momeni P, McKeith IG, Burn DJ, Keir G, Larner AJ, Mann DM, Perry R (2012) Frontotemporal dementia in elderly individuals. Arch Neurol 69, 1052-1060.
18. Forman MS, Farmer J, Johnson JK, Clark CM, Arnold SE, Coslett HB, Chatterjee A, Hurtig HI, Karlawish JH, Rosen HJ, Van D, V, Lee VM, Miller BL, Trojanowski JQ, Grossman M( 2006) Frontotemporal dementia: Clinicopathological correlations. Ann Neurol 59, 952-962.
19. Knibb JA, Xuereb JH, Patterson K, Hodges JR (2006) Clinical and pathological characterization of progressive aphasia. Ann Neurol 59, 156-165.
20. Hu WT, Chen-Plotkin A, Grossman M, Arnold SE, Clark CM, Shaw LM, McCluskey L, Elman L, Hurtig HI, Siderowf A, Lee VM, Soares H, Trojanowski JQ (2010) Novel CSF biomarkers for frontotemporal lobar degenerations. Neurology 75, 2079-2086.
21. Schoonenboom NS, Reesink FE,Verwey NA,Kester MI, Teunissen CE, van deVen PM, Pijnenburg YA, Blankenstein MA, Rozemuller AJ, Scheltens P, Van der Flier WM (2012) Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort. Neurology 78, 47-54.
22. Visser PJ, Verhey F, Knol DL, Scheltens P, Wahlund LO, Freund-Levi Y, Tsolaki M, Minthon L, Wallin AK, Hampel H, Burger K, Pirttila T, Soininen H, Rikkert MO, Verbeek MM, Spiru L, Blennow K (2009) Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: A prospective cohort study. Lancet Neurol 8, 619-627.
23. Bian H, van Swieten JC, Leight S, Massimo L,Wood E, Forman M, Moore P, de KI, Clark CM, Rosso S, Trojanowski J, Lee VM, Grossman M (2008) CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology 70, 1827-1835.
24. Borroni B, Premi E, Di LM, Padovani A (2007) Combined biomarkers for early Alzheimer disease diagnosis. Curr Med Chem 14, 1171-1178.
25. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P (2010) Revising the definition of Alzheimer's disease: A new lexicon. Lancet Neurol 9, 1118-1127.
26. Borroni B, Premi E, Agosti C, Alberici A, Cerini C, Archetti S, Lanari A, Paghera B, Lucchini S, Caimi L, Padovani A (2011) CSF Alzheimer's disease-like pattern in corticobasal syndrome: Evidence for a distinct disorder. J Neurol Neurosurg Psychiatry 82, 834-838.
27. Kas A, Uspenskaya O, Lamari F, de Souza LC, Habert MO, Dubois B, Teichmann M, Sarazin M (2012) Distinct brain perfusion pattern associated with CSF biomarkers profile in primary progressive aphasia. J Neurol Neurosurg Psychiatry 83, 695-698.
28. Toledo JB, Brettschneider J, Grossman M, Arnold SE, Hu WT, Xie SX, Lee VM, Shaw LM, Trojanowski JQ (2012) CSF biomarkers cutoffs: The importance of coincident neuropathological diseases. Acta Neuropathol 124, 23-35.
29. Borroni B, Agosti C, Premi E, Cerini C, Cosseddu M, Paghera B, Bellelli G, Padovani A(2010) The FTLD-modified clinical dementia rating scale is a reliable tool for defining disease severity in frontotemporal lobar degeneration: Evidence from a brain SPECT study. Eur J Neurol 17, 703-707.
30. Premi E, Garibotto V, Alberici A, Paghera B, Giubbini R, Padovani A, Borroni B (2012) Nature versus nurture in frontotemporal lobar degeneration: The interaction of genetic background and education on brain damage. Dement Geriatr Cogn Disord 33, 372-378.
31. Mesulam M,Wicklund A, Johnson N, Rogalski E, Leger GC, Rademaker A,Weintraub S, Bigio EH (2008) Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol 63, 709-719.
32. Clark CM, Xie S, Chittams J, Ewbank D, Peskind E, Galasko D, Morris JC, McKeel DW Jr., Farlow M, Weitlauf SL, Quinn J, Kaye J, Knopman D, Arai H, Doody RS, DeCarli C, Leight S, Lee VM, Trojanowski JQ (2003) Cerebrospinal fluid tau and beta-amyloid: How well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol 60, 1696-1702.
33. Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttila T (2009) Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol 66, 382-389.
34. Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, Van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek M, Tsolaki M, Mulugeta E, Rosen E, Aarsland D, Visser PJ, Schroder J, Marcusson J, de LM, Hampel H, Scheltens P, Pirttila T,Wallin A, Jonhagen ME, Minthon L,Winblad B, Blennow K (2009) CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 302, 385-393.
35. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr., Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 263-269.
36. Whitwell JL, Jack CR Jr., Przybelski SA, Parisi JE, Senjem ML, Boeve BF, Knopman DS, Petersen RC, Dickson DW, Josephs KA (2011) Temporoparietal atrophy: A marker of AD pathology independent of clinical diagnosis. Neurobiol Aging 32, 1531-1541.
37. Grossman M, Libon DJ, Forman MS, Massimo L, Wood E, Moore P, Anderson C, Farmer J, Chatterjee A, Clark CM, Coslett HB, Hurtig HI, Lee VM, Trojanowski JQ (2007) Distinct antemortem profiles in patients with pathologically defined frontotemporal dementia. Arch Neurol 64, 1601-1609.
38. Jellinger KA, Attems J (2010) Prevalence of dementia disorders in the oldest-old: An autopsy study. Acta Neuropathol 119, 421-433.
39. Wallon D, Rovelet-Lecrux A, Deramecourt V, Pariente J, Auriacombe S, Le B, Schraen I, Pasquier S, Campion F, Hannequin D, D (2012) Definite behavioral variant of frontotemporal dementia with C9ORF72 expansions despite positive Alzheimer's disease cerebrospinal fluid biomarkers. J Alzheimers Dis 32, 19-22.
40. Ferrari R, Mok K, Moreno JH, Cosentino S, Goldman J, Pietrini P, Mayeux R, Tierney MC, Kapogiannis D, Jicha GA, Murrell JR, Ghetti B, Wassermann EM, Grafman J, Hardy J, Huey ED, Momeni P (2012) Screening for C9ORF72 repeat expansion in FTLD. Neurobiol Aging 33, 1850-1811.
41. Boutoleau-Bretonniere C, Lebouvier T, Delaroche O, Lamy E, Evrard C, Charriau T, Bretonniere C, Damier P, Derkinderen P, Vercelletto M (2012) Value of neuropsychological testing, imaging, and CSF biomarkers for the differential diagnosis and prognosis of clinically ambiguous dementia. J Alzheimers Dis 28, 323-336.
42. Cohen AD, Rabinovici GD, Mathis CA, Jagust WJ, Klunk WE, Ikonomovic MD (2012) Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta. Adv Pharmacol 64, 27-81.